Dermatologic toxicology in children

Current Problems in Dermatology

Volumn 12, Issue 3, 2000, Pages 118-122

  Spray, Angela ^a   Siegfried, Elaine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; ALPHA INTERFERON; ANTIHISTAMINIC AGENT; BLEOMYCIN; CALCIPOTRIOL; CANTHARIDIN; CIDOFOVIR; CIMETIDINE; CORTICOSTEROID; CYPROHEPTADINE; DIPHENHYDRAMINE; EMLA; FORMALDEHYDE; GLUTARALDEHYDE; IMIQUIMOD; IODINE DERIVATIVE; ITRACONAZOLE; PODOPHYLLOTOXIN; POVIDONE IODINE; PRILOCAINE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RETINOID; SALICYLIC ACID; SULFADIAZINE SILVER; TACROLIMUS; TOPICAL AGENT;

ADRENAL INSUFFICIENCY; ARGYRIA; AUTONOMIC DYSFUNCTION; BLOOD TOXICITY; CHILD; CHILDHOOD DISEASE; GLAUCOMA; GROWTH RETARDATION; HISTORY; HUMAN; HYPERTENSION; HYPOCALCEMIA; METABOLIC DISORDER; METHEMOGLOBINEMIA; NEPHROTOXICITY; NEUROTOXICITY; NEWBORN; OSTEOPOROSIS; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS TUMOR; PREMATURITY; REVIEW; RISK FACTOR; SKIN ABSORPTION; SKIN TOXICITY; THYROID DISEASE;

EID: 0034072449     PISSN: 10400486     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-0486(00)90033-4     Document Type: Review

References (44)

1. Rutter N. Percutaneous drug absorption in the newborn: hazards and uses. Clin Perinatol 1987;14(4):911.
2. Dinehart AM, Dillard R, Raimer SS, et al. Cutaneous manifestations of acrodynia (pink disease). Arch Dermatol 1988; 124:107.
3. Armstrong RW, Eichner ER, Klein DE, et al. Pentachlorophenl poisoning in a nursery for newborn infants. II. Epidemiologic and toxicology studies. J Pediatr 1969;75(2): 317.
4. Shuman RM, Leech RW, Alvord EC. Neurotoxicity of hexachlorophene in the human. A clinicopathologic study of 248 children. Pediatrics 1974;54:689.
5. Fairley JA, Rasmussen JE. Comparison of stratum corneum thickness in children and adults. J Am Acad Dermatol 1983; 8(5):652.
6. West DP, Worobec S, Solomon LM. Pharmacology and toxicology of infant skin. The Journal of Investigative Dermatology 1981;76:147.
7. Morselli PL. Clinical pharmacokinetics in neonates. Clin Pharmacokinet 1976;1:81.
8. Williams ML. Hazards and potential hazards. In; Frieden IJ, Eichenfield LF, Esterly NB (eds). Textbook of Neonatal Dermatology, WB Saunders Co (in print)
9. Siegfried EC. Neonatal skin and skin care. Pediatric Dermatology 1998;16(3):437.
10. Frayling IM, Addison GM, Chattergee K, et al. Methaemo-globinaemia in children treated with prilocaine lignocaine cream. Br Med Journal 1990;301:153.
11. de Waard-van der Spek FB, Oranje AP. Purpura caused by Emla is of toxic origin. Contact Dermatitis 1997;36(1): 11.
12. Calobrisi SD, Drolet BA, Esterly NB. Petechial eruption after the application of EMLA cream. Pediatrics 1998;101 (3 pt 1):471.
13. In press (personal communication, L. Eichenfield)
14. Linder N, Davidovitch N, Reichman B et al. Topical iodinecontaining antiseptics and subclinical hypothyroidism in preterm infants. J Pediatr 1997;131(3):434.
15. Parravicini E, Fontana C, Paterlini GL, et al. Iodine, thyroid function, and very low birth weight infants. Pediatrics 1996; 98(4):730.
16. Paul DA, Leef KH, Stefano JL, et al. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics 1998;101(5):903.
17. Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334 (13):821.
18. Roberts, RJ. Drug Therapy in Infants: Pharmacologic Principles and Clinical Experience. Philadelphia, W.B. Saunders Company, 1984, pp 341-343.
19. Furnas HJ. Silvadene toxicity. Plast Reconstr Surg 1991;88 (4):735.
20. Viala J, Simon L, LePommelet C, et al. Agranulocytosis after application of silver sulfadiazine in a 2 month old infant. Archives de Pediatric 1997;4(11)1103.
21. Choban PS, Marshall WJ. Leukopenia secondary to silver sulfadiazine: frequency, characteristics, and clinical consequences. American Surgeon 1987;53(9)515.
22. Bernhardt DT. Topical diphenhydramine toxicity. Wis Med J 1991;90(8):469.
23. Reilly JF, Weisse ME. Topically induced diphenhydramine toxicity. J Emerg Med 1990;8(1):59.
24. McGann KP, Pribanich S, Graham JA et al. Diphenhydramine toxicity in a child with varicella. A case report. J Fam Pract 1992;35(2):213.
25. Watemberg NM, Roth KS, Alehan FK et al. Central anticholinergic syndrome on therapeutic doses of cyproheptadine. Pediatrics 1999;103(1):158.
26. Oranje AP, Marcoux D, Svensson A. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997;36(2 pt 1): 203.
27. Theirs BH. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. J Am Acad Dermatol 1997;37(3 pt 2):S69.
28. Langner A, Verjans H, Stapor V. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. Br J Dermatol 1993;128(5):566.
29. Hoeck HC, Laurberg G, Laurberg P. Hypercalcaemic crisis after excessive topical use of a vitamin D derivative. J Int Medicine 1994;235(3):281.
30. Drake LA, Dinehart SM, Farmer ER et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol 1996;35:615.
31. Schafer-Korting M, Schmid MH, Korting HC. Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept. Drug Safety 1996; 14(6): 375.
32. Hepburn D, Morelli J, Weston WL. Topical steroid holiday. Pediatrics 1995;95(3):455.
33. Gupta AK, Adam P, Hofstader SL. Itraconazole oral solution for the treatment of onychomycosis. Pediatric Dermatology 1998;15(6):472.
34. deRepentigny L, Ratelle J, Leclerc JM. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children. Antimicrob Agents Chemother 1998;42(2): 404.
35. Murdock KM. Sporanox. Janssen Pharmaceutica Research Foundation. Titusville, NJ, 1999.
36. Boguniewicz M, Fiedler VC, Raimer S, et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998;102(4 pt 1):637.
37. Hanifin JM. Use of tacrolimus ointment in 3-6 year olds with atopic dermatitis. Presented at the Society of Investigative Dermatology meeting in Cologne, Germany in May 1998. Provided by Hodosh E. Fufisawa USA, Inc. Deerfield, IL, 1998.
38. McKee M, Segev D, Wise B, et al. Initial experience with FK506 in pediatric renal transplant recipients. J Pediatr Surg 1997;32(5)688.
39. Kershner RP, Fitzsimmons WE. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 1996;62:920-6.
40. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon alfa-2b. J Pediatr Hematol Oncol 1997;19:237.
41. Nako Y, Fukushima N, Igarashi T, et al. Successful interferon therapy in neonate with life-threatening Kasabach-Merritt syndrome. J Perinatol 1997;17(3):244.
42. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2 treatment of hemangiomas of infancy. J Pediatr 1998;132:527.
43. Grether JK, Nelson KB, Dambrosia JM, et al. Interferons and cerebral palsy. J Pediatr 1999;134(3):324.
44. Kalia YN, Merino V, Guy RH. Transdermal drug delivery. Derm Clinics 1998;16(2):289.